MindMaze Therapeutics (0QKQ) Names Prof. John W. Krakauer as Strategic Advisor to Drive US Market Expansion

MindMaze Therapeutics (0QKQ) Names Prof. John W. Krakauer as Strategic Advisor to Drive US Market Expansion →

MindMaze Therapeutics Holding SA (SIX: MMTX; 0QKQ), a Geneva-based leader in scalable precision neurotherapeutics, has appointed Professor John W. Krakauer as a strategic advisor to advance its growth in the United States. Krakauer, the ori…